PharmaResearch Statistics

Total Valuation

PharmaResearch has a market cap or net worth of KRW 3.45 trillion. The enterprise value is 3.25 trillion.

Market Cap	3.45T
Enterprise Value	3.25T

Important Dates

The next estimated earnings date is Friday, May 9, 2025.

Earnings Date	May 9, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

PharmaResearch has 10.39 million shares outstanding. The number of shares has decreased by -2.50% in one year.

Current Share Class	n/a
Shares Outstanding	10.39M
Shares Change (YoY)	-2.50%
Shares Change (QoQ)	-1.73%
Owned by Insiders (%)	38.61%
Owned by Institutions (%)	19.03%
Float	5.20M

Valuation Ratios

The trailing PE ratio is 37.13 and the forward PE ratio is 25.90. PharmaResearch's PEG ratio is 0.90.

PE Ratio	37.13
Forward PE	25.90
PS Ratio	9.76
PB Ratio	6.39
P/TBV Ratio	6.80
P/FCF Ratio	33.91
P/OCF Ratio	n/a
PEG Ratio	0.90

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 23.28, with an EV/FCF ratio of 31.97.

EV / Earnings	35.33
EV / Sales	9.29
EV / EBITDA	23.28
EV / EBIT	25.80
EV / FCF	31.97

Financial Position

The company has a current ratio of 6.75, with a Debt / Equity ratio of 0.37.

Current Ratio	6.75
Quick Ratio	5.84
Debt / Equity	0.37
Debt / EBITDA	1.49
Debt / FCF	2.05
Interest Coverage	27.20

Financial Efficiency

Return on equity (ROE) is 17.23% and return on invested capital (ROIC) is 12.35%.

Return on Equity (ROE)	17.23%
Return on Assets (ROA)	11.33%
Return on Invested Capital (ROIC)	12.35%
Return on Capital Employed (ROCE)	16.29%
Revenue Per Employee	856.03M
Profits Per Employee	225.04M
Employee Count	409
Asset Turnover	0.50
Inventory Turnover	1.84

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +229.04% in the last 52 weeks. The beta is 0.54, so PharmaResearch's price volatility has been lower than the market average.

Beta (5Y)	0.54
52-Week Price Change	+229.04%
50-Day Moving Average	290,780.00
200-Day Moving Average	215,974.00
Relative Strength Index (RSI)	58.63
Average Volume (20 Days)	86,331

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PharmaResearch had revenue of KRW 350.12 billion and earned 92.04 billion in profits. Earnings per share was 8,940.87.

Revenue	350.12B
Gross Profit	251.24B
Operating Income	126.05B
Pretax Income	115.81B
Net Income	92.04B
EBITDA	139.70B
EBIT	126.05B
Earnings Per Share (EPS)	8,940.87

Full Income Statement

Balance Sheet

The company has 437.35 billion in cash and 208.79 billion in debt, giving a net cash position of 228.57 billion or 21,999.34 per share.

Cash & Cash Equivalents	437.35B
Total Debt	208.79B
Net Cash	228.57B
Net Cash Per Share	21,999.34
Equity (Book Value)	570.12B
Book Value Per Share	51,917.28
Working Capital	472.40B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 138.12 billion and capital expenditures -36.41 billion, giving a free cash flow of 101.71 billion.

Operating Cash Flow	138.12B
Capital Expenditures	-36.41B
Free Cash Flow	101.71B
FCF Per Share	9,789.28

Full Cash Flow Statement

Margins

Gross margin is 71.76%, with operating and profit margins of 36.00% and 26.29%.

Gross Margin	71.76%
Operating Margin	36.00%
Pretax Margin	33.08%
Profit Margin	26.29%
EBITDA Margin	39.90%
EBIT Margin	36.00%
FCF Margin	29.05%

Dividends & Yields

This stock pays an annual dividend of 1,100.00, which amounts to a dividend yield of 0.33%.

Dividend Per Share	1,100.00
Dividend Yield	0.33%
Dividend Growth (YoY)	15.79%
Years of Dividend Growth	5
Payout Ratio	10.96%
Buyback Yield	2.50%
Shareholder Yield	2.83%
Earnings Yield	2.67%
FCF Yield	2.95%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

PharmaResearch has an Altman Z-Score of 5.49.

Altman Z-Score	5.49
Piotroski F-Score	n/a